Noticias

On this page, you can find recent news concerning the Anticancer Fund, cancer, and cancer therapies.

Anticancer Fund News

A new guide for patients available - Non-Conventional Treatment Options in Breast Cancer

Fuente: 
Fundación contra el càncer

Thanks to the financial support of the lingerie firm Van de Velde the guide “Non-Conventional Treatment Options in Breast Cancer” was created by a team of scientists at the Anticancer Fund.

FDA press release: FDA takes action against 14 companies for selling illegal cancer treatments

Fuente: 
Fundación contra el càncer

14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer.

New guide for patients available on nutrition in cancer cachexia

Fuente: 
Fundación contra el càncer

Cachexia is a problem that doesn’t receive enough attention during a cancer treatment.

Press release: Common Heart Drug Repurposed to Treat Rare Cancer in Europe

Fuente: 
Fundación contra el càncer

Orphan Drug Designation Confirms Propranolol’s Treatment Benefits

Growing evidence that exercise is safe and beneficial for cancer patients and cancer survivors.

Fuente: 
Fundación contra el càncer

Recent findings on breast cancer confirm that exercise may decrease fatigue and increase energy during breast cancer treatment.

PIONEER: a randomised Phase II trial in early stage, operable ER+ breast cancer patients - new publication in 'Nature Reviews Cancer'

Fuente: 
Fundación contra el càncer

A new paper in the journal Nature Reviews Cancer, ‘Deciphering the divergent roles of progestogens in breast cancer’, outlines the complex role of progestogens in ER positive breast cancer.

Press release: First patient enrolled in brain tumor trial combining 9 repurposed drugs - CUSP9v3

Fuente: 
Fundación contra el càncer

The Anticancer Fund is pleased to announce that on Tuesday 15th November 2016, the first patient was enrolled in a clinical trial called CUSP9v3 for recurrent glioblastoma at the Department of Neurosurgery, University Hospital of Ulm, Germany.

Press release: It's time to consider propranolol as an anti-cancer drug, researchers say

Fuente: 
Fundación contra el càncer

The common beta-blocker has significant anti-cancer properties.

New data from a retrospective study with aspirine in advanced colorectal cancer patients

Fuente: 
Fundación contra el càncer

New data from a retrospective study in advanced colorectal cancer patients taking aspirin concurrently indicates that it may have some positive effects on clinical outcomes.

Inspiring video of Dyanne: the war against lung cancer

Fuente: 
Fundación contra el càncer

The story of Dyanne, a 31 year old lung cancer patient and her war against lung cancer.

Noticias externas